The Met protooncogene is a transcriptional target of NF kappaB: implications for cell survival.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 2868332)

Published in J Cell Biochem on August 15, 2009

Authors

James Y Dai1, Marie C DeFrances, Chunbin Zou, Carla J Johnson, Reza Zarnegar

Author Affiliations

1: Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

Articles cited by this

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30

Met, metastasis, motility and more. Nat Rev Mol Cell Biol (2003) 14.30

NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol (2005) 13.98

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science (1998) 11.70

Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature (1995) 6.13

Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A (1997) 4.33

Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A (2004) 4.17

Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer (2002) 3.89

Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell (1992) 3.73

Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol Cell Biol (1993) 3.51

NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc Natl Acad Sci U S A (1999) 2.83

Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes Dev (1999) 2.82

Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol (2002) 2.81

Met provides essential signals for liver regeneration. Proc Natl Acad Sci U S A (2004) 2.77

Lack of Fas antagonism by Met in human fatty liver disease. Nat Med (2007) 2.48

Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc Natl Acad Sci U S A (1996) 2.35

NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest (1998) 2.27

HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J (1996) 2.09

Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res (2002) 2.05

NFkappaB-dependent signaling pathways. Exp Hematol (2002) 1.98

Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology (1998) 1.96

A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell (2002) 1.82

Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Differ (1995) 1.75

Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. Cancer Res (1999) 1.74

The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J Biol Chem (1991) 1.71

Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology (2007) 1.68

Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology (1999) 1.64

Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem (1994) 1.64

Liver regeneration. Adv Biochem Eng Biotechnol (2005) 1.42

Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ (1996) 1.36

Expression of the c-met protooncogene in human hepatocellular carcinoma. Hepatology (1994) 1.21

Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene (1994) 1.19

Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1. Oncogene (2000) 1.19

Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines. Hepatology (1997) 1.18

Regenerative changes in C/EBP alpha and C/EBP beta expression modulate binding to the C/EBP site in the c-fos promoter. Hepatology (1994) 1.17

Coexistence of C/EBP alpha, beta, growth-induced proteins and DNA synthesis in hepatocytes during liver regeneration. Implications for maintenance of the differentiated state during liver growth. J Clin Invest (1995) 1.17

The presence of hepatocyte growth factor in the developing rat. Development (1992) 1.15

u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma. Int J Cancer (2000) 1.12

Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene (1998) 1.10

Ets up-regulates MET transcription. Oncogene (1996) 1.06

The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice. Oncogene (1999) 1.02

Regulation of the c-met proto-oncogene promoter by p53. J Biol Chem (1999) 0.99

Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Cell Growth Differ (1996) 0.97

Structure and inducible regulation of the human MET promoter. J Biol Chem (1994) 0.93

Activation and regulation of NFkappaB during acute inflammation. Clin Chem Lab Med (1999) 0.87

Structural and functional characterization of the mouse c-met proto-oncogene (hepatocyte growth factor receptor) promoter. Biochim Biophys Acta (1998) 0.82

Expression of the hepatocyte growth factor receptor in the regenerating rat liver. Cancer Lett (1993) 0.77

Articles by these authors

A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat Immunol (2013) 2.60

Lack of Fas antagonism by Met in human fatty liver disease. Nat Med (2007) 2.48

Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res (2002) 2.05

A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell (2002) 1.82

Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res (2007) 1.74

F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation. Nat Immunol (2012) 1.28

F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. Blood (2012) 1.16

PIK3IP1, a negative regulator of PI3K, suppresses the development of hepatocellular carcinoma. Cancer Res (2008) 1.13

PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein. Biochem Biophys Res Commun (2007) 1.09

Models and determinants of vocabulary growth from kindergarten to adulthood. J Child Psychol Psychiatry (2008) 1.04

Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure. J Immunol (2008) 1.04

Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer. J Clin Invest (2009) 0.99

Targeting F box protein Fbxo3 to control cytokine-driven inflammation. J Immunol (2013) 0.99

A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med (2011) 0.97

A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem (2003) 0.96

Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J Biol Chem (2003) 0.94

The contribution of processing impairments to SLI: insights from attention-deficit/hyperactivity disorder. J Commun Disord (2009) 0.92

Extracellular signal-regulated kinase (ERK) regulates cortactin ubiquitination and degradation in lung epithelial cells. J Biol Chem (2012) 0.89

Emerging adult outcomes of adolescent psychiatric and substance use disorders. Addict Behav (2009) 0.89

Promotion of Fas-mediated apoptosis in Type II cells by high doses of hepatocyte growth factor bypasses the mitochondrial requirement. J Cell Physiol (2007) 0.85

SCF E3 ligase F-box protein complex SCF(FBXL19) regulates cell migration by mediating Rac1 ubiquitination and degradation. FASEB J (2013) 0.85

Novel Death Defying Domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes. Hepatology (2014) 0.82

The role of phonological recoding in orthographic learning. J Exp Child Psychol (2005) 0.82

Lipopolysaccharide triggers nuclear import of Lpcat1 to regulate inducible gene expression in lung epithelia. World J Biol Chem (2012) 0.81

Single-word and conversational measures of word-finding proficiency. Am J Speech Lang Pathol (2003) 0.78

Narrative abilities in monolingual and dual language learning children with specific language impairment. J Commun Disord (2010) 0.78

Histone deacetylase 2 (HDAC2) protein-dependent deacetylation of mortality factor 4-like 1 (MORF4L1) protein enhances its homodimerization. J Biol Chem (2014) 0.76